People
Susan Silbermann
Led Vaccine Company before its acquisition by Eli Lilly; previously held global vaccine and emerging-markets leadership roles at Pfizer.
Roles
Vaccine Company
CurrentChief Executive Officer & Board Director (before 2026 acquisition)